HannahH.BrowneHannahH., GeraldG.MasonGeraldG., ThomasT.TangThomasT., Retinoids and pregnancy: an update, „The Obstetrician & Gynaecologist”, 16 (1), 2014, s. 7–11, DOI: 10.1111/tog.12075, ISSN1744-4667 [dostęp 2018-01-02](ang.).1 stycznia
R.R.MittendorfR.R., Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero, „Teratology”, 51 (6), 1995, s. 435–445, DOI: 10.1002/tera.1420510609, ISSN0040-3709, PMID: 7502243 [dostęp 2018-01-02].
EE.HemminkiEE., MM.GisslerMM., HH.ToukomaaHH., Exposure to female hormone drugs during pregnancy: effect on malformations and cancer, „British Journal of Cancer”, 80 (7), 1999, s. 1092–1097, DOI: 10.1038/sj.bjc.6690469, ISSN0007-0920, PMID: 10362122, PMCID: PMC2363045 [dostęp 2018-01-02].
RinatR.HackmonRinatR., MonicaM.BlichowskiMonicaM., GideonG.KorenGideonG., The safety of methimazole and propylthiouracil in pregnancy: a systematic review, „Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC”, 34 (11), 2012, s. 1077–1086, DOI: 10.1016/S1701-2163(16)35438-X, ISSN1701-2163, PMID: 23231846 [dostęp 2018-01-03].
F.J.E.F.J.E.VajdaF.J.E.F.J.E. i inni, The teratogenicity of the newer antiepileptic drugs - an update, „Acta Neurologica Scandinavica”, 130 (4), 2014, s. 234–238, DOI: 10.1111/ane.12280, ISSN1600-0404, PMID: 25040242 [dostęp 2018-01-02].
AlbertoA.VerrottiAlbertoA. i inni, Foetal safety of old and new antiepileptic drugs, „Expert Opinion on Drug Safety”, 14 (10), 2015, s. 1563–1571, DOI: 10.1517/14740338.2015.1084288, ISSN1744-764X, PMID: 26329145 [dostęp 2018-01-02].
ElisabettaE.PatornoElisabettaE. i inni, Lithium Use in Pregnancy and the Risk of Cardiac Malformations, „The New England journal of medicine”, 376 (23), 2017, s. 2245–2254, DOI: 10.1056/NEJMoa1612222, ISSN0028-4793, PMID: 28591541, PMCID: PMC5667676 [dostęp 2018-01-02].
CC.LebaudyCC. i inni, Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy, „Clinical Pharmacology & Therapeutics”, 84 (3), 2008, s. 370–377, DOI: 10.1038/clpt.2008.73, PMID: 18431408.
PunamP.SachdevaPunamP., B.G.B.G.PatelB.G.B.G., B.K.B.K.PatelB.K.B.K., Drug Use in Pregnancy; a Point to Ponder!, „Indian Journal of Pharmaceutical Sciences”, 71 (1), 2009, s. 1–7, DOI: 10.4103/0250-474X.51941, ISSN0250-474X, PMID: 20177448, PMCID: PMC2810038 [dostęp 2018-01-03].
doi.org
AE. Czeizel, J. Métneki, Z. Kazy, E. Puho. A population-based case-control study of oral griseofulvin treatment during pregnancy.. „Acta Obstet Gynecol Scand”. 83 (9), s. 827-31, Sep 2004. DOI: 10.1111/j.0001-6349.2004.00598.x. PMID: 15315593.
Sai-Ching JimS.Ch.J.YeungSai-Ching JimS.Ch.J., Carmen P.C.P.EscalanteCarmen P.C.P., Robert F.R.F.GagelRobert F.R.F., Medical Care of Cancer Patients, PMPH-USA, 2009, ISBN 978-1-60795-008-0 [dostęp 2018-01-02](ang.). Brak numerów stron w książce
Thomas J.T.J.HaleyThomas J.T.J., William O.W.O.BerndtWilliam O.W.O., Toxicology, CRC Press, 27 lutego 2002, s. 346, ISBN 978-0-89116-810-2 [dostęp 2018-01-03](ang.).
H. Knothe, GA. Dette. Antibiotics in pregnancy: toxicity and teratogenicity.. „Infection”. 13 (2), s. 49-51, 1985. PMID: 2987132.
M.F.M.F.KleinM.F.M.F., J.R.J.R.BeallJ.R.J.R., Griseofulvin: a teratogenic study, „Science”, 175 (4029), 1972, s. 1483–1484, ISSN0036-8075, PMID: 5013681 [dostęp 2017-12-31].
AE. Czeizel, J. Métneki, Z. Kazy, E. Puho. A population-based case-control study of oral griseofulvin treatment during pregnancy.. „Acta Obstet Gynecol Scand”. 83 (9), s. 827-31, Sep 2004. DOI: 10.1111/j.0001-6349.2004.00598.x. PMID: 15315593.
R.R.MittendorfR.R., Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero, „Teratology”, 51 (6), 1995, s. 435–445, DOI: 10.1002/tera.1420510609, ISSN0040-3709, PMID: 7502243 [dostęp 2018-01-02].
EE.HemminkiEE., MM.GisslerMM., HH.ToukomaaHH., Exposure to female hormone drugs during pregnancy: effect on malformations and cancer, „British Journal of Cancer”, 80 (7), 1999, s. 1092–1097, DOI: 10.1038/sj.bjc.6690469, ISSN0007-0920, PMID: 10362122, PMCID: PMC2363045 [dostęp 2018-01-02].
RinatR.HackmonRinatR., MonicaM.BlichowskiMonicaM., GideonG.KorenGideonG., The safety of methimazole and propylthiouracil in pregnancy: a systematic review, „Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC”, 34 (11), 2012, s. 1077–1086, DOI: 10.1016/S1701-2163(16)35438-X, ISSN1701-2163, PMID: 23231846 [dostęp 2018-01-03].
D. HeatherD.H.WattsD. HeatherD.H., Teratogenicity risk of antiretroviral therapy in pregnancy, „Current HIV/AIDS reports”, 4 (3), 2007, s. 135–140, ISSN1548-3568, PMID: 17883999 [dostęp 2018-01-02].
RachelR.AlsdorfRachelR., Diego F.D.F.WyszynskiDiego F.D.F., Teratogenicity of sodium valproate, „Expert Opinion on Drug Safety”, 4 (2), 2005, s. 345–353, ISSN1744-764X, PMID: 15794725 [dostęp 2018-01-02].
F.J.E.F.J.E.VajdaF.J.E.F.J.E. i inni, The teratogenicity of the newer antiepileptic drugs - an update, „Acta Neurologica Scandinavica”, 130 (4), 2014, s. 234–238, DOI: 10.1111/ane.12280, ISSN1600-0404, PMID: 25040242 [dostęp 2018-01-02].
AlbertoA.VerrottiAlbertoA. i inni, Foetal safety of old and new antiepileptic drugs, „Expert Opinion on Drug Safety”, 14 (10), 2015, s. 1563–1571, DOI: 10.1517/14740338.2015.1084288, ISSN1744-764X, PMID: 26329145 [dostęp 2018-01-02].
I.I.NulmanI.I. i inni, Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications, „American Journal of Medical Genetics”, 68 (1), 1997, s. 18–24, ISSN0148-7299, PMID: 8986270 [dostęp 2018-01-02].
ElisabettaE.PatornoElisabettaE. i inni, Lithium Use in Pregnancy and the Risk of Cardiac Malformations, „The New England journal of medicine”, 376 (23), 2017, s. 2245–2254, DOI: 10.1056/NEJMoa1612222, ISSN0028-4793, PMID: 28591541, PMCID: PMC5667676 [dostęp 2018-01-02].
CC.LebaudyCC. i inni, Changes in enoxaparin pharmacokinetics during pregnancy and implications for antithrombotic therapeutic strategy, „Clinical Pharmacology & Therapeutics”, 84 (3), 2008, s. 370–377, DOI: 10.1038/clpt.2008.73, PMID: 18431408.
PunamP.SachdevaPunamP., B.G.B.G.PatelB.G.B.G., B.K.B.K.PatelB.K.B.K., Drug Use in Pregnancy; a Point to Ponder!, „Indian Journal of Pharmaceutical Sciences”, 71 (1), 2009, s. 1–7, DOI: 10.4103/0250-474X.51941, ISSN0250-474X, PMID: 20177448, PMCID: PMC2810038 [dostęp 2018-01-03].
HannahH.BrowneHannahH., GeraldG.MasonGeraldG., ThomasT.TangThomasT., Retinoids and pregnancy: an update, „The Obstetrician & Gynaecologist”, 16 (1), 2014, s. 7–11, DOI: 10.1111/tog.12075, ISSN1744-4667 [dostęp 2018-01-02](ang.).1 stycznia
R.R.MittendorfR.R., Teratogen update: carcinogenesis and teratogenesis associated with exposure to diethylstilbestrol (DES) in utero, „Teratology”, 51 (6), 1995, s. 435–445, DOI: 10.1002/tera.1420510609, ISSN0040-3709, PMID: 7502243 [dostęp 2018-01-02].
Kumar i inni, Robbins patologia, wyd. 1 pol, Wrocław: Urban & Partner, [cop. 2005], ISBN 978-83-89581-92-1, OCLC69448413. Brak numerów stron w książce
EE.HemminkiEE., MM.GisslerMM., HH.ToukomaaHH., Exposure to female hormone drugs during pregnancy: effect on malformations and cancer, „British Journal of Cancer”, 80 (7), 1999, s. 1092–1097, DOI: 10.1038/sj.bjc.6690469, ISSN0007-0920, PMID: 10362122, PMCID: PMC2363045 [dostęp 2018-01-02].
RinatR.HackmonRinatR., MonicaM.BlichowskiMonicaM., GideonG.KorenGideonG., The safety of methimazole and propylthiouracil in pregnancy: a systematic review, „Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC”, 34 (11), 2012, s. 1077–1086, DOI: 10.1016/S1701-2163(16)35438-X, ISSN1701-2163, PMID: 23231846 [dostęp 2018-01-03].
D. HeatherD.H.WattsD. HeatherD.H., Teratogenicity risk of antiretroviral therapy in pregnancy, „Current HIV/AIDS reports”, 4 (3), 2007, s. 135–140, ISSN1548-3568, PMID: 17883999 [dostęp 2018-01-02].
RachelR.AlsdorfRachelR., Diego F.D.F.WyszynskiDiego F.D.F., Teratogenicity of sodium valproate, „Expert Opinion on Drug Safety”, 4 (2), 2005, s. 345–353, ISSN1744-764X, PMID: 15794725 [dostęp 2018-01-02].
F.J.E.F.J.E.VajdaF.J.E.F.J.E. i inni, The teratogenicity of the newer antiepileptic drugs - an update, „Acta Neurologica Scandinavica”, 130 (4), 2014, s. 234–238, DOI: 10.1111/ane.12280, ISSN1600-0404, PMID: 25040242 [dostęp 2018-01-02].
AlbertoA.VerrottiAlbertoA. i inni, Foetal safety of old and new antiepileptic drugs, „Expert Opinion on Drug Safety”, 14 (10), 2015, s. 1563–1571, DOI: 10.1517/14740338.2015.1084288, ISSN1744-764X, PMID: 26329145 [dostęp 2018-01-02].
I.I.NulmanI.I. i inni, Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications, „American Journal of Medical Genetics”, 68 (1), 1997, s. 18–24, ISSN0148-7299, PMID: 8986270 [dostęp 2018-01-02].
ElisabettaE.PatornoElisabettaE. i inni, Lithium Use in Pregnancy and the Risk of Cardiac Malformations, „The New England journal of medicine”, 376 (23), 2017, s. 2245–2254, DOI: 10.1056/NEJMoa1612222, ISSN0028-4793, PMID: 28591541, PMCID: PMC5667676 [dostęp 2018-01-02].
PunamP.SachdevaPunamP., B.G.B.G.PatelB.G.B.G., B.K.B.K.PatelB.K.B.K., Drug Use in Pregnancy; a Point to Ponder!, „Indian Journal of Pharmaceutical Sciences”, 71 (1), 2009, s. 1–7, DOI: 10.4103/0250-474X.51941, ISSN0250-474X, PMID: 20177448, PMCID: PMC2810038 [dostęp 2018-01-03].
